← All Sponsors
SPONSOR

Ascentage Pharma Group Inc.

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Acute Myeloid Leukemia
NCT06389292 Phase 3
Recruiting

A Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid Leukemia

Acute Myeloid Leukemia
China, Russia View Trial →